Multiple Ascending Dose Study of HM12460A in Type 2 Diabetes Mellitus
Clinical trial NCT03332836 · TERMINATED
Trial details
- NCT number
- NCT03332836
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-25
- Primary completion
- 2019-01-30
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.